About this trial
The goal of this clinical trial is to investigate if a 3-dimensional fabricated nasal mesh works to close nasal septal perforations. Under general anesthesia, during nasal septal perforation repair surgery, the investigator will place the mesh between the elevated mucoperichondrial flaps opposite the site of the perforation and confirm its original position at both sides under nasal endoscope. Endoscopic examination for septal mucosa status will be done monthly for a three months follow up period.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing nasal septal perforation repair surgery.
Disqualifiers
Patients with known allergy to polycaprolactone.
Pregnancy or lactation.
Trial design
Single group
Treatments tested in this trial
Polycaprolactone nasal mesh
Devicea 3-dimensional fabricated Polycaprolactone nasal mesh
Treatment groups
Trial outcomes
Primary outcomes
Mean Change in Post-operative healing of septal perforation
Endoscopic evaluation of nasal septal mucosa status will be classified as complete bilateral healing, complete unilateral healing, no healing, and perforation.
Secondary outcomes
Postoperative complications
The following complications will be evaluated on a present/absent basis:hematoma-infection-allergy
Sponsors and contacts
Click on the lead sponsor to view all of their trials.